Glutathione S-transferase variants and their interaction with smoking on lung function

被引:62
作者
He, JQ
Connett, JE
Anthonisen, NR
Paré, PD
Sandford, AJ [1 ]
机构
[1] St Pauls Hosp, James Hogg iCAPTURE Ctr Cardiovasc & Pulm Res, Vancouver, BC V6Z 1Y6, Canada
[2] Univ Manitoba, Fac Med, Winnipeg, MB, Canada
[3] Univ Minnesota, Sch Publ Hlth, Div Biostat, Minneapolis, MN 55455 USA
关键词
cigarette smoking; FEV1; gene-environment interaction; genetic polymorphism; glutathione S-transferase;
D O I
10.1164/rccm.200312-1763OC
中图分类号
R4 [临床医学];
学科分类号
1002 [临床医学]; 100602 [中西医结合临床];
摘要
We studied glutathione S-transferase (GST) polymorphisms in 1,098 whites with the lowest (n = 544, FEV1 % predicted mean +/- SEM 62.6 +/- 0.1) and the highest (n = 554, FEV1 % predicted mean SEM 91.8 +/- 0.1) lung function at the beginning of the Lung Health Study. Homozygosity for GSTP1 105Val was significantly more frequent in the low- than in the high-function group (13.2 vs. 9.3%) (odds ratio = 1.69, 95% confidence interval [CI] = 1.11-2.61, p = 0.016), after adjustment for confounding variables. Subjects with 105Val homozygotes had higher rates of lung function decline in the high-function group (p = 0.017). The frequencies of GSTM1, GSTT1 null genotypes were similar between the high- and low-function groups, but subjects with the GSTT1 null genotype had a faster decline of lung function in the low-function group (p 0.032). In addition, there was a significant interaction of GSTT1 genotype and pack-years on lung function. When comparing individuals with GSTT1 null genotype with wild type, the adjusted odds ratio was 3.49 (95% Cl, 1.48-8.39, p = 0.005) in mild smokers (less than or equal to 25 pack years). We conclude that GST genotypes are risk factors for rapid decline or low lung function in smokers with mild to moderate airflow obstruction.
引用
收藏
页码:388 / 394
页数:7
相关论文
共 63 条
[1]
AliOsman F, 1997, J BIOL CHEM, V272, P10004
[2]
EFFECTS OF SMOKING INTERVENTION AND THE USE OF AN INHALED ANTICHOLINERGIC BRONCHODILATOR ON THE RATE OF DECLINE OF FEV(1) - THE LUNG HEALTH STUDY [J].
ANTHONISEN, NR ;
CONNETT, JE ;
KILEY, JP ;
ALTOSE, MD ;
BAILEY, WC ;
BUIST, AS ;
CONWAY, WA ;
ENRIGHT, PL ;
KANNER, RE ;
OHARA, P ;
OWENS, GR ;
SCANLON, PD ;
TASHKIN, DP ;
WISE, RA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 272 (19) :1497-1505
[3]
Genetic polymorphisms in human xenobiotica metabolizing enzymes as susceptibility factors in toxic response [J].
Autrup, H .
MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS, 2000, 464 (01) :65-76
[4]
DIFFERENTIAL SUSCEPTIBILITY TO TOBACCO-SMOKE - POSSIBLE MECHANISMS [J].
BASCOM, R .
PHARMACOGENETICS, 1991, 1 (02) :102-106
[5]
Clinical, radiologic, and induced sputum features of chronic obstructive pulmonary disease in nonsmokers - A descriptive study [J].
Birring, SS ;
Brightling, CE ;
Bradding, P ;
Entwisle, JJ ;
Vara, DD ;
Grigg, J ;
Wardlaw, AJ ;
Pavord, ID .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 166 (08) :1078-1083
[6]
Cheng L, 1999, INT J CANCER, V84, P220, DOI 10.1002/(SICI)1097-0215(19990621)84:3<220::AID-IJC4>3.0.CO
[7]
2-S
[8]
CONNETT JE, 1993, CONTROLLED CLIN TRIA, V14, P3
[9]
CUMULATIVE AND REVERSIBLE EFFECTS OF LIFETIME SMOKING ON SIMPLE TESTS OF LUNG-FUNCTION IN ADULTS [J].
DOCKERY, DW ;
SPEIZER, FE ;
FERRIS, BG ;
WARE, JH ;
LOUIS, TA ;
SPIRO, A .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1988, 137 (02) :286-292
[10]
SPIROMETRY IN THE LUNG HEALTH STUDY .1. METHODS AND QUALITY-CONTROL [J].
ENRIGHT, PL ;
JOHNSON, LR ;
CONNETT, JE ;
VOELKER, H ;
BUIST, AS .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1991, 143 (06) :1215-1223